NCT07413263 2026-02-18
Impact of Tyrosine Kinase Inhibitors on Glucose Level and Lipid Metabolism in Chronic Myeloid Leukemia Patients
Assiut University
Not yet recruiting
Clinical Trials
11 trialsNCT07091019 2025-07-29
ASC4REAL-2
Novartis
Not yet recruiting
NCT01860456 2025-06-05
TIKlet
University of Pisa
Completed
NCT05286528 2023-10-27
Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database
Pfizer
Completed
NCT05734053 2023-08-21
NOFRETETE
Novartis
Completed
NCT03885830 2023-01-11
Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients
UNC Lineberger Comprehensive Cancer Center
Completed
NCT00976612 2020-01-07
Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST): Nilotinib PK
Asan Medical Center
Completed
NCT02421926 2019-07-08
IDEAL-E
Asan Medical Center
Withdrawn
NCT03331211 2017-11-08
Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia
Nanfang Hospital, Southern Medical University
Unknown
NCT02733445 2016-04-11
Metabolic Outcomes in Patients Receiving Tyrosine Kinase Inhibitor (TKI) Therapy With Dasatinib or Nilotinib
Bristol-Myers Squibb
Completed
NCT01562847 2014-01-13
AMICAN
Seoul St. Mary's Hospital
Unknown